Influenza A virus vaccine H5N1 - Adimmune Corporation
Alternative Names: AdimFlu-W; AdimFlu-W (H5N1); AdimFlu-W (H5N1) Pandemic Influenza Vaccine - AdimmuneLatest Information Update: 27 Dec 2019
At a glance
- Originator Adimmune Corporation
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza A virus H5N1 subtype
Most Recent Events
- 27 Dec 2019 Discontinued - Phase-I/II for Influenza A virus H5N1 subtype (Prevention) in Taiwan (IM) (Adimmune Corporation website, December 2019)
- 14 Dec 2015 Clinical development is ongoing in Taiwan
- 01 Jul 2012 Phase-I/II clinical trials in Influenza-A virus H5N1 subtype (prevention) in Taiwan (IM)